Close Menu

equity investment

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SeraCare Life Sciences has signed a definitive agreement to be acquired by private equity firm Linden Capital Partners for $4 per share, or around $82 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – A new company called Oxford Cancer Biomarkers has been formed to provide oncology consulting services and new cancer biomarkers.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has sold its stake in Rosetta Green, a majority owned subsidiary of the firm, for an upfront payment of $900,000.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – GenoLogics today said that it has raised $8 million in a private round of financing led by Illumina, a new investor in the firm.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Nxt2b has signed an agreement to purchase 49 percent of all outstanding shares of Swedish protein and molecular technologies firm Olink Bioscience for an undisclosed amount.

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.